HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean G MacFadyen Selected Research

Iron

1/2020Effects of Interleukin-1β Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean G MacFadyen Research Topics

Disease

15Myocardial Infarction
12/2022 - 11/2008
11Inflammation (Inflammations)
01/2023 - 01/2017
10Cardiovascular Diseases (Cardiovascular Disease)
11/2022 - 01/2004
7Stroke (Strokes)
10/2020 - 11/2008
7Unstable Angina
10/2018 - 11/2008
6Thrombosis (Thrombus)
01/2023 - 10/2017
6Atherosclerosis
12/2022 - 10/2017
5Neoplasms (Cancer)
10/2017 - 11/2008
3Venous Thromboembolism
11/2022 - 04/2009
3Infections
01/2020 - 01/2017
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 08/2012
2Gout
01/2023 - 10/2018
2Type 2 Diabetes Mellitus (MODY)
11/2022 - 01/2019
2Heart Failure
01/2020 - 06/2015
2Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2019
2Muscular Diseases (Myopathy)
06/2013 - 11/2008
2Myalgia
06/2013 - 04/2011
2Hyperlipidemias (Hyperlipidemia)
11/2009 - 11/2008
1Non-alcoholic Fatty Liver Disease
11/2022
1Hypertriglyceridemia
11/2022
1Neutropenia
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Anemia
01/2020
1Skin Neoplasms (Skin Cancer)
01/2019
1Chronic Renal Insufficiency
01/2018
1Lung Neoplasms (Lung Cancer)
10/2017
1Neoplasm Metastasis (Metastasis)
10/2017
1Sepsis (Septicemia)
10/2017
1Muscle Weakness
04/2011
1Diabetes Mellitus
04/2011
1Dyslipidemias (Dyslipidemia)
03/2010
1Ischemic Stroke
01/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
04/2009
1Wounds and Injuries (Trauma)
04/2009
1Pulmonary Embolism
04/2009
1Vascular Diseases (Vascular Disease)
02/2009

Drug/Important Bio-Agent (IBA)

18C-Reactive ProteinIBA
01/2023 - 11/2008
12Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023 - 11/2008
11canakinumabFDA Link
01/2023 - 01/2017
11Rosuvastatin Calcium (Crestor)FDA Link
06/2013 - 11/2008
8LDL CholesterolIBA
11/2022 - 11/2008
7CholesterolIBA
01/2023 - 11/2008
6Interleukin-6 (Interleukin 6)IBA
01/2020 - 10/2017
5Monoclonal AntibodiesIBA
01/2019 - 01/2017
4InterleukinsIBA
10/2020 - 10/2017
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2020
3LipidsIBA
01/2023 - 01/2017
3omega-Chloroacetophenone (Mace)IBA
12/2022 - 10/2018
3InflammasomesIBA
01/2020 - 10/2017
2HDL CholesterolIBA
11/2022 - 07/2010
2CytokinesIBA
01/2020 - 01/2020
2LDL Lipoproteins (beta Lipoproteins)IBA
07/2011 - 11/2008
1very low density lipoprotein triglycerideIBA
11/2022
1(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
11/2022
1HDL LipoproteinsIBA
11/2022
1TabletsIBA
11/2022
1Triglycerides (Triacylglycerol)IBA
11/2022
1Apolipoprotein C-IIIIBA
11/2022
1methotrexate polyglutamateIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1IronIBA
01/2020
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1EnzymesIBA
01/2019
1Uric Acid (Urate)IBA
10/2018
1NLR ProteinsIBA
10/2017
1Proteins (Proteins, Gene)FDA Link
10/2017
1Vitamin DFDA LinkGeneric
03/2016
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
03/2016
1AnionsIBA
06/2013
1Peptides (Polypeptides)IBA
06/2013
1Glucose (Dextrose)FDA LinkGeneric
08/2012
1A 17 (A-17)IBA
08/2012
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
05/2012
1oxidized low density lipoproteinIBA
04/2011
1Apolipoprotein A-I (Apolipoprotein A1)IBA
07/2010
1AntioxidantsIBA
01/2004
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2004
1VitaminsIBA
01/2004

Therapy/Procedure

12Therapeutics
01/2023 - 02/2009
2Aftercare (After-Treatment)
10/2018 - 05/2012
1Secondary Prevention
01/2020